Zepbound and Mounjaro are essentially the same medication for weight loss. Both contain the identical active ingredient, tirzepatide, and are made by the same company, Eli Lilly. The only true difference between them is their FDA-approved purpose and how they are marketed and covered by insurance.
The choice between them comes down to your primary health condition and insurance coverage, not which one will work better.
📋 The Real Difference: A Question of Labels
| Feature | Zepbound | Mounjaro |
|---|---|---|
| Active Ingredient | Tirzepatide | Tirzepatide |
| FDA-Approved Use | Chronic weight management for adults with obesity or overweight with a related condition | Type 2 diabetes to improve blood sugar control |
| Insurance Coverage | Often requires coverage for weight-loss medications, which many plans exclude | Typically covered under a plan’s diabetes benefits |
| Weight Loss Effect | Clinically proven for weight loss. In trials, users lost an average of 20.9% of their body weight | While primarily for diabetes, it also leads to significant weight loss, showing results identical to Zepbound in clinical trials |
💡 Key Points to Remember
-
Identical Effectiveness: Since they are the same drug, neither is “better” for weight loss. The clinical trial results showing up to 20.9% average weight loss apply to both.
-
The Role of Insurance: Your doctor’s choice of which one to prescribe will likely be guided by what your insurance will cover. If you need weight loss medication, Zepbound is the appropriate indication, but if you also have type 2 diabetes, Mounjaro may be more easily covered
Zepbound and Mounjaro for weight loss – buy tirzepatide prescription free